β-Funaltrexamine (β-FNA) and the regulation of body and brain development in rats

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The effects of β-FNA, a highly selective and irreversible μ opioid receptor antagonist, in altering body and brain development in preweaning rats were determined. Animals given β-FNA did not differ from controls in body weights, brain and cerebellar weights, macroscopic dimensions of the brain, the area of the cerebellum, or in organ weight. The dosage of β-FNA utilized (5 mg/kg) blocked morphine-induced analgesia (2 mg/kg morphine sulfate, SC) for each injection period (i.e., 48 hr). In contrast to β-FNA treatment, rats given naltrexone (50 mg/kg SC) in a regimen which completely blocked the opioid receptor throughout ontogeny exhibited marked increases in somatic and neurobiological growth. These results suggest that, in and by themselves, μ receptors selectively antagonized by β-FNA do not play an important role in regulating development.

Original languageEnglish (US)
Pages (from-to)5-9
Number of pages5
JournalBrain Research Bulletin
Volume17
Issue number1
DOIs
StatePublished - Jan 1 1986

Fingerprint

Morphine
Brain
Naltrexone
Narcotic Antagonists
Organ Size
Opioid Receptors
Analgesia
Cerebellum
Body Weight
Weights and Measures
Injections
Growth
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{4a0f41e5a74f40ef962650d7e9128edf,
title = "β-Funaltrexamine (β-FNA) and the regulation of body and brain development in rats",
abstract = "The effects of β-FNA, a highly selective and irreversible μ opioid receptor antagonist, in altering body and brain development in preweaning rats were determined. Animals given β-FNA did not differ from controls in body weights, brain and cerebellar weights, macroscopic dimensions of the brain, the area of the cerebellum, or in organ weight. The dosage of β-FNA utilized (5 mg/kg) blocked morphine-induced analgesia (2 mg/kg morphine sulfate, SC) for each injection period (i.e., 48 hr). In contrast to β-FNA treatment, rats given naltrexone (50 mg/kg SC) in a regimen which completely blocked the opioid receptor throughout ontogeny exhibited marked increases in somatic and neurobiological growth. These results suggest that, in and by themselves, μ receptors selectively antagonized by β-FNA do not play an important role in regulating development.",
author = "Ian Zagon and Patricia McLaughlin",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0361-9230(86)90155-3",
language = "English (US)",
volume = "17",
pages = "5--9",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "1",

}

β-Funaltrexamine (β-FNA) and the regulation of body and brain development in rats. / Zagon, Ian; McLaughlin, Patricia.

In: Brain Research Bulletin, Vol. 17, No. 1, 01.01.1986, p. 5-9.

Research output: Contribution to journalArticle

TY - JOUR

T1 - β-Funaltrexamine (β-FNA) and the regulation of body and brain development in rats

AU - Zagon, Ian

AU - McLaughlin, Patricia

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The effects of β-FNA, a highly selective and irreversible μ opioid receptor antagonist, in altering body and brain development in preweaning rats were determined. Animals given β-FNA did not differ from controls in body weights, brain and cerebellar weights, macroscopic dimensions of the brain, the area of the cerebellum, or in organ weight. The dosage of β-FNA utilized (5 mg/kg) blocked morphine-induced analgesia (2 mg/kg morphine sulfate, SC) for each injection period (i.e., 48 hr). In contrast to β-FNA treatment, rats given naltrexone (50 mg/kg SC) in a regimen which completely blocked the opioid receptor throughout ontogeny exhibited marked increases in somatic and neurobiological growth. These results suggest that, in and by themselves, μ receptors selectively antagonized by β-FNA do not play an important role in regulating development.

AB - The effects of β-FNA, a highly selective and irreversible μ opioid receptor antagonist, in altering body and brain development in preweaning rats were determined. Animals given β-FNA did not differ from controls in body weights, brain and cerebellar weights, macroscopic dimensions of the brain, the area of the cerebellum, or in organ weight. The dosage of β-FNA utilized (5 mg/kg) blocked morphine-induced analgesia (2 mg/kg morphine sulfate, SC) for each injection period (i.e., 48 hr). In contrast to β-FNA treatment, rats given naltrexone (50 mg/kg SC) in a regimen which completely blocked the opioid receptor throughout ontogeny exhibited marked increases in somatic and neurobiological growth. These results suggest that, in and by themselves, μ receptors selectively antagonized by β-FNA do not play an important role in regulating development.

UR - http://www.scopus.com/inward/record.url?scp=0022471073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022471073&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(86)90155-3

DO - 10.1016/0361-9230(86)90155-3

M3 - Article

C2 - 3019487

AN - SCOPUS:0022471073

VL - 17

SP - 5

EP - 9

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 1

ER -